241 related articles for article (PubMed ID: 18945270)
1. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.
Halbsguth U; Rentsch KM; Eich-Höchli D; Diterich I; Fattinger K
Br J Clin Pharmacol; 2008 Dec; 66(6):781-91. PubMed ID: 18945270
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.
Girardin F; Rentsch KM; Schwab MA; Maggiorini M; Pauli-Magnus C; Kullak-Ublick GA; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2003 Oct; 74(4):341-52. PubMed ID: 14534521
[TBL] [Abstract][Full Text] [Related]
3. Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics.
Rentsch KM; Kullak-Ublick GA; Reichel C; Meier PJ; Fattinger K
Clin Pharmacol Ther; 2001 Sep; 70(3):237-46. PubMed ID: 11557911
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.
Rook EJ; van Ree JM; van den Brink W; Hillebrand MJ; Huitema AD; Hendriks VM; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):86-96. PubMed ID: 16433897
[TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
[TBL] [Abstract][Full Text] [Related]
7. Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets.
Perger L; Rentsch KM; Kullak-Ublick GA; Verotta D; Fattinger K
Eur J Pharm Sci; 2009 Mar; 36(4-5):421-32. PubMed ID: 19084595
[TBL] [Abstract][Full Text] [Related]
8. Morphine and 6-acetylmorphine concentrations in blood, brain, spinal cord, bone marrow and bone after lethal acute or chronic diacetylmorphine administration to mice.
Guillot E; de Mazancourt P; Durigon M; Alvarez JC
Forensic Sci Int; 2007 Mar; 166(2-3):139-44. PubMed ID: 16730149
[TBL] [Abstract][Full Text] [Related]
9. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients.
Klous MG; Van den Brink W; Van Ree JM; Beijnen JH
Drug Alcohol Depend; 2005 Dec; 80(3):283-95. PubMed ID: 15916865
[TBL] [Abstract][Full Text] [Related]
10. A prospective cohort study on orally administered heroin substitution for severely addicted opioid users.
Frick U; Rehm J; Kovacic S; Ammann J; Uchtenhagen A
Addiction; 2006 Nov; 101(11):1631-9. PubMed ID: 17034443
[TBL] [Abstract][Full Text] [Related]
11. Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin.
Rook EJ; van Zanten AP; Van den Brink W; van Ree JM; Beijnen JH
Drug Alcohol Depend; 2006 Dec; 85(3):185-90. PubMed ID: 16765536
[TBL] [Abstract][Full Text] [Related]
12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting.
Colom Farran J; Casas M; Pérez de Los Cobos J; Del Río M; Roncero C; Castells X; Valero S; Eiroa-Orosa FJ; Batlle F; Trujols J
Eur Addict Res; 2012; 18(6):279-87. PubMed ID: 22854605
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.
Zandvliet AS; Huitema AD; de Jonge ME; den Hoed R; Sparidans RW; Hendriks VM; van den Brink W; van Ree JM; Beijnen JH
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):71-9. PubMed ID: 15667599
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
17. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.
Ward ME; Woodhouse A; Mather LE; Farr SJ; Okikawa JK; Lloyd P; Schuster JA; Rubsamen RM
Clin Pharmacol Ther; 1997 Dec; 62(6):596-609. PubMed ID: 9433388
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]